Inventor · disambiguated record
Ulrike Gerdemann
Also filed as: GERDEMANN ULRIKE
6 granted patents·6 pending applications·29 citations·filing 2010–2023
80Inventor score
Top patents by PatentIndex Score
12 records- 0193US11118164B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2018·Granted Sep 14, 2021·7 cites·14 claims
- 0291US10385316B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Aug 20, 2019·8 cites·15 claims
- 0389US9963677B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesLEEN ANN M·Filed 2010·Granted May 8, 2018·14 cites·28 claims
- 0485US2023357721A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 0583US2023114971A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0682US12435309B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Granted Oct 7, 2025·0 cites·8 claims
- 0780US11981923B2Pepmixes to generate multiviral CTLS with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2022·Granted May 14, 2024·0 cites·11 claims
- 0877US12227764B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Feb 18, 2025·0 cites·21 claims
- 0967US2019264176A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1066US2019144826A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1162US2015010519A1Pepmixes to generate multiviral ctls with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 1257US2025177528A1Regulatory t cells with chimeric antigen receptor targeting co-stimulatory molecules to prevent and/or treat inflammatory conditionsCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrike Gerdemann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →